Search Results

Now showing 1 - 4 of 4
  • PublicationJournal Article
    In this research, we propose a theoretical model which helps us to consider evolutions of some special heart cells by using superconducting quantum interface devices (SQUID) in a magnetocardiography (MCG) technique. In this model, each cell has its own special electrical structure including ions and charges. These charges move within or outside the cell and emit some magnetic fields. Also, some charges have spins which emit spinning magnetic fields. Summing over these biofields produces the real biofield of a cell. All cellular magnetic fields are summed and enter into the sensor (SQUID) and form the observed pulse on the scope. On the other hand, each biofield induces a current on the superconductor of detector. To consider evolutions of a special cell, one can produce some currents, equal and in opposite directions of currents which are induced by other cells. These currents cancel effects of other cells and only the current and magnetic field of a desired cell is remained. Thus, one can analyze the behavior of one special cell. For example, if a cell converts to a tumor one, its radiated charges and magnetic fields are changed. These changes could be detected by SQUID and tumors could be diagnosed fast.
    • 1
    • 16
    • 0
  • PublicationJournal Article
    The worldwide expanding increment in cancer pervasiveness is disturbing and this disease ranks among the main causes of mortality in both developing and developed countries. Unfortunately, available treatment options come with serious side effects and do not guarantee complete success. Although numerous models have been proposed for the development of better therapeutic agent, however the exact mechanism are still poorly understood. This then calls for continued research aimed at developing new drugs as an alternative or adjuvant anticancer agents. Here we have identified five vital proteins (CDK-2, Bcl-2, CDK-6, VEGFR, and IGF-1R) that aid tumor growth and we inhibited the activity of these proteins with Puerarin. Puerarin is an isoflavonoid C-glycosides used as a therapeutic agent against various human ailments. Our findings revealed that Puerarin fulfilled Veber’s rule. Added to this, CDK-6 and Bcl-2 had better glide scores for puerarin than the control (doxorubicin) and molecular simulation showed the stability of the complexes. These findings suggest that inhibiting CDK-6 and Bcl-2 with Puerarin could prove more effective in the management of cancer than doxorubicin. Overall, this study provides a new direction that could facilitate rational drug design for cancer.
    • 1
    • 3
    • 0
  • PublicationJournal Article
    The ability of Natural Killer (NK) cells to eliminate cancerous cells is largely dependant on the activation of the stimulatory or co-stimulatory natural killer group 2, member D (NKG2D) receptor. This receptor recognises ligands that are structural homologs of MHC class I molecules such as the UL-16 binding protein 2 (ULBP2). ULBP2 has been reported to have the ability to mediate natural resistance against tumours in vivo, thus promoting its use as a potential target for developing immunotherapeutic agents for the treatment of cancers and some viral infections. In this study, we generated a reliable and quality 3-D structure of the protein using SWISS-MODEL. Furthermore, the ULBP2 was forecasted to be antigenic in nature and possesses six linear B-cell epitopes and 11 discontinuous B-cell epitopes. The protein contains seven cytotoxic T lymphocytes (CTLs) and two helper T lymphocytes (HTLs). Overall, potential epitopes that might be effective to produce the B-cell and T-cell mediated immunity towards the needed immune response to tumour growth was predicted.
    • 1
    • 1
    • 0
  • PublicationJournal Article
    Cancer and bacterial diseases have been the most incidental diseases to date. According to the World Health Report 2018, at least every family is affected by cancer around the world. In 2012, 14.1 million people were affected by cancer, and that figure is bound to increase to 21.6 million in 2030. Medicine therefore sorts out ways of treatment using conventional methods which have been proven to have many side effects. Researchers developed photothermal and photodynamic methods to treat both cancer and bacterial diseases. These methods pose fewer effects on the biological systems but still no perfect method has been synthesized. The review serves to explore porphyrin and gold nanorods to be used in the treatment of cancer and bacterial diseases: porphyrins as photosensitizers and gold nanorods as delivery agents. In addition, the review delves into ways of incorporating photothermal and photodynamic therapy aimed at producing a less toxic, more efficacious, and specific compound for the treatment.
    • 1
    • 0
    • 0